Meet: Dr. Ahmed Bourghida, Chief Scientific Officer at RMDM
In the first of several posts, we are delighted to introduce various members of the RMDM team. This week, we talk to Dr. Ahmed Bourghida, Chief Scientific Officer at RMDM about…Read full story »
Liquid Biopsy: The Future of Cancer Diagnostics
The gold standard in cancer detection has always been tissue biopsy. But the procedure is invasive, time-consuming, and often painful or stressful for patients. More…Read full story »
PanTum Detect: The solution to the COVID effect on Cancer?
‘The knock-on impact of the pandemic on cancer care cannot be overstated’. These are the words of Steven McIntosh, the executive director of advocacy and communications at…Read full story »
RMDM Publishes Whitepaper on Universal Cancer Blood Test
RMDM is delighted to announce the publication of a whitepaper on PanTum Detect: the first blood test for the early detection of all cancers. The whitepaper follows our partnership…Read full story »